This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Diagnosis and Treatment

Alfred E. Stillman, MD; David L. Earnest, MD; James M. Woolfenden, MD

Am J Dis Child. 1985;139(1):41-45.

Abstract
• A 9-year-old child with congenital hepatic fibrosis had dilated intrahepatic bile ducts and recurrent cholangitis. Choleretic agents were administered to prevent recurrent cholangitis. Response to treatment was monitored with serum bile acid concentrations and computer-assisted technetium Tc 99m iprofenin (Pipida) scintigraphy. Dehydrocholic acid with meals improved hepatobiliary excretion of the radioactive isotope and lowered serum bile acid levels but did not prevent cholangitic attacks when used alone. Sulfamethoxazole and trimethoprim used alone prevented infection, but a steady rise in serum bile acid concentrations suggested increasing cholestasis. During combined drug treatment, the patient remained free of cholangitis for at least two years. Optimal therapy of congenital hepatic fibrosis with cholestasis but without mechanical biliary obstruction may involve the combined use of a choleretic such as dehydrocholic acid plus a suppressive antibiotic.

(AJDC 1985;139:41-45)

Author Affiliations
From the Tucson Hospitals Medical Education Program, and the Departments of Pediatrics (Dr Stillman), Internal Medicine (Dr Earnest), and Nuclear Medicine (Dr Woolfenden), University of Arizona College of Medicine, Tucson. Dr Stillman is now with Harrington Memorial Hospital, Southbridge, Mass.

Footnotes
Reprint requests to Department of Internal Medicine, Arizona Health Sciences Center, 1501 N Campbell Ave, Tucson, AZ 85724 (Dr Earnest).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?